![Kaisa Helminen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kaisa Helminen
Operationeel Directeur bij AIFORIA TECHNOLOGIES OYJ
Vermogen: 637 433 $ op 31-05-2024
Actieve functies van Kaisa Helminen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AIFORIA TECHNOLOGIES OYJ | Operationeel Directeur | 01-07-2020 | - |
Algemeen Directeur | 01-06-2014 | 01-07-2020 |
Loopbaan van Kaisa Helminen
Eerdere bekende functies van Kaisa Helminen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sartorius Biohit Liquid Handling Oy
![]() Sartorius Biohit Liquid Handling Oy Electronic Equipment/InstrumentsElectronic Technology Part of Sartorius AG, Sartorius Biohit Liquid Handling Oy manufactures measuring and controlling devices. The company is based in Helsinki, Finland. | Corporate Officer/Principal | 01-05-2012 | 01-06-2014 |
Thermo Fisher Scientific Oy
![]() Thermo Fisher Scientific Oy Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Thermo Fisher Scientific Oy is a Finnish company that manufactures and supplies medical and dental instruments. The company is based in Vanda, Finland. The CEO of the company is Timo Tapio Hildén. | Corporate Officer/Principal | 01-01-2011 | 01-05-2012 |
Finnzymes Oy
![]() Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Corporate Officer/Principal | 01-02-2001 | 01-01-2011 |
Opleiding van Kaisa Helminen
University of Helsinki | Graduate Degree |
Statistieken
Internationaal
Finland | 6 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Sectoraal
Health Technology | 3 |
Technology Services | 2 |
Electronic Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AIFORIA TECHNOLOGIES OYJ | Technology Services |
Bedrijven in privébezit | 3 |
---|---|
Sartorius Biohit Liquid Handling Oy
![]() Sartorius Biohit Liquid Handling Oy Electronic Equipment/InstrumentsElectronic Technology Part of Sartorius AG, Sartorius Biohit Liquid Handling Oy manufactures measuring and controlling devices. The company is based in Helsinki, Finland. | Electronic Technology |
Thermo Fisher Scientific Oy
![]() Thermo Fisher Scientific Oy Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Thermo Fisher Scientific Oy is a Finnish company that manufactures and supplies medical and dental instruments. The company is based in Vanda, Finland. The CEO of the company is Timo Tapio Hildén. | Health Technology |
Finnzymes Oy
![]() Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Health Technology |
- Beurs
- Insiders
- Kaisa Helminen
- Ervaring